Frank Glorius

Frank Glorius (born 1972 in Walsrode) is a German chemist and W3-Professor of organic chemistry in the Department of Chemistry and Pharmacy at the Westfälische Wilhelms-Universität in Münster.[1]

Life and work

Glorius studied chemistry at the Leibniz University Hannover, completing his Diploma thesis in 1997. During his Diploma he also undertook a nine-month research stay at Stanford University with Paul A. Wender in 1995/1996.[2] Glorius completed his Doctorate in 2000 investigating "New chiral bis-oxazoline ligands for enantioselective catalysis" at the University of Basel with Andreas Pfaltz. His PhD was divided between the Max-Planck-Institut für Kohlenforschung (1997–1999) and the University of Basel (1999–2000). Between 2000–2001 Glorius completed a Postdoc at Harvard University in Cambridge, with David A. Evans exploring the Total synthesis of Aflastatin A. Following this, he worked with his mentor Alois Fürstner as an independent researcher/research group leader/Assistant Professor at the Max-Planck-Institut für Kohlenforschung. In 2004, before formal completion of the habilitation, he was awarded a position as C3-Professor of Chemistry at the University of Marburg. Since August 2007, Glorius has been a Professor of Organic Chemistry at Westfälische Wilhelms-Universität in Münster.

Professor Glorius' research program is dedicated to the development of new catalytic methodologies in organic chemistry. His research group explores a wide range of topics including the development and application of N-heterocyclic carbenes (NHCs) in catalysis,[3] C-H activation,[4] asymmetric organocatalysis,[5] asymmetric hydrogenation of aromatic compounds, photoredox catalysis, heterogeneous catalysis, Metal Organic Frameworks/MOFs, and the development of reaction screening technologies.[6]

Former members of the group have gone on to have careers in both academia (e.g. Canada, China, France, Germany, India and Japan) and industry (BASF, Bayer, Evonik, Clariant, Axalta, Lanxess, Continental, Archimica, Mitsubishi, Novartis or Janssen Pharmaceutica (Johnson & Johnson) for instance).

Honors and awards

Research Awards: Glorius has received numerous grants, prizes and awards. In his early career, he was awarded the Liebig-scholarship of the Fonds der Chemischen Industrie (2001–2004), the ORCHEM-Award for Scientists (2004), and the BASF Catalysis Award (2005). Of particular note was the Alfried Krupp Prize in 2006, for €1 million, the ERC Independent Researcher Starting Grant, worth €1.5 million, in 2010, and the Gottfried Wilhelm Leibniz Prize, in 2013, from the German Research Foundation, valued at €2.5 million.[7] Additionally, he has received the OMCOS Award in 2011, and the Springer Heterocyclic Chemistry Award in 2012. In 2013, he was elected as an honorary member of the Israel Chemical Society, and was named as a 2015 and 2014 Thomson Reuters Highly Cited Researcher in 2014.[8] Glorius also received the Novartis Chemistry Lectureship Award for 2014/2015 and the inaugurational SYNLETT Best Paper Award 2015.[9]

Teaching Award: In addition, in 2014 Frank Glorius was awarded by the students of the Department of Chemistry&Pharmacy of the WWU Muenster with the "Goldener Brendel" for excellence in teaching.

Glorius sits on the boards of numerous committees and societies, including the Kuratorium (Board of Trustees) of the Fonds der Chemischen Industrie, the selection committee of the Humboldt foundation for incoming postdocs, the German Catalysis Society (GeCatS) and the Münster branch of the German Chemical Society (2011–2014).

References

  1. ↑ Homepage der Arbeitsgruppe von Prof. Frank Glorius an der WWU Münster
  2. ↑ Paul A. Wender, Frank Glorius u. a.: Transition Metal-Catalyzed [5 + 2] Cycloadditions of Allenes and Vinylcyclopropanes: First Studies of Endo-Exo Selectivity, Chemoselectivity, Relative Stereochemistry, and Chirality Transfer. In: Journal of the American Chemical Society. 121, 1999, S. 5348–5349, doi:10.1021/ja9903072.
  3. ↑ Matthew N. Hopkinson, Christian Richter, Michael Schedler, Frank Glorius: An overview of N-heterocyclic carbenes. In: Nature. 510, 2014, S. 485–496, doi:10.1038/nature13384.
  4. ↑ Joanna Wencel-Delord, Frank Glorius: C-H bond activation enables the rapid construction and late-stage diversification of functional molecules. In: Nature Chemistry. 5, 2013, S. 369–375, doi:10.1038/nchem.1607.
  5. ↑ Xavier Bugaut, Frank Glorius: Organocatalytic umpolung: N-heterocyclic carbenes and beyond. In: Chemical Society Reviews. 41, 2012, S. 3511, doi:10.1039/C2CS15333E.
  6. ↑ Karl D. Collins, Frank Glorius: A robustness screen for the rapid assessment of chemical reactions. In: Nature Chemistry. 5, 2013, S. 597–601, doi:10.1038/nchem.1669.
  7. ↑ Pressemeldung Leibniz-Preis
  8. ↑ 2014 Thomson Reuters Highly Cited Researcher
  9. ↑ Synlett Award announcement
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.